Beetham Thomas W.

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$217,045.17
Insider Sells Quantity
6
Insider Sells Sum
$3.86M

Insider Activity of Beetham Thomas W.

According to the SEC Form 4 filings, Beetham Thomas W., being in a position of

  1. Chief Operating Officer at Viridian Therapeutics, Inc.,
    оver the last 12 months, has bought 5000 shares for $117,050, and sold 0 shares,
    over all time since 2024-09-27, has bought 5000 shares for $117,050, and sold 0 shares.

The largest purchase of all time was on 2024-09-27 and amounted to 5000 shares of Viridian Therapeutics, Inc. for $117,050.

The largest sale of all time was on 2020-04-20 and amounted to 94846 shares of Kiniksa Pharmaceuticals, Ltd. for $1.81M.

Biography of Beetham Thomas W.

No biography is available at this moment.

2024-09-27PurchaseViridian Therapeutics, Inc.
VRDN
Chief Operating Officer
5,000
0.0066%
$23.41$117,050+0.9%
2021-02-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
4,954
0.0076%
$22.09$109,434-36.09%
2020-07-01SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
59,178
0.0892%
$25.37$1.5M-30.75%
2020-06-10SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
27,504
0.0261%
$13.33$366,628-24.94%
2020-04-21SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
5,036
0.0059%
$13.82$69,613-5.23%
2020-04-20SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
94,846
0.1643%
$19.06$1.81M+2.13%
2020-02-14SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
118
0.0002%
$18.58$2,192+8.02%
2018-02-09PurchaseKiniksa Pharmaceuticals, Ltd.
KNSA
Chief Legal Officer
12,784
$7.82$99,995
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.